Literature DB >> 12431840

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists.

Dimitris K Grammatopoulos1, George P Chrousos.   

Abstract

Corticotropin-releasing hormone (CRH) plays a major role in coordinating the behavioral, endocrine, autonomic and immune responses to stress. CRH and CRH-related peptides and their receptors are present in the central nervous system and in a wide variety of peripheral tissues, including the immune, cardiovascular and reproductive systems, and have been associated with the pathophysiology of many disease states. These observations have led to the development of several CRH receptor type-selective antagonists, which have been used experimentally to elucidate the role of CRH and related peptides in physiological and disease processes, such as anxiety and depression, sleep disorders, addictive behavior, inflammatory and allergic disorders, neurological diseases and pre-term labor. Because of the complex network of multiple CRH receptor subtypes and their tissue- and agonist-specific signaling diversity, antagonists need to be developed that can target specific CRH receptor isoform-driven signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431840     DOI: 10.1016/s1043-2760(02)00670-7

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  70 in total

1.  Lipopolysaccharide upregulates the expression of corticotropin-releasing hormone via MAP kinase pathway in rat peritoneal macrophages.

Authors:  Wuchao Wang; Xiuzhu Zhang; Lie Yang; Dawei Liu; Guodong Liu; Jihong Zhou
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

2.  CRH functions as a growth factor/cytokine in the skin.

Authors:  A Slominski; B Zbytek; A Pisarchik; R M Slominski; M A Zmijewski; J Wortsman
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

Review 3.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 4.  Neuroendocrine system of the skin.

Authors:  Andrzej Slominski
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

Review 5.  Corticotropin releasing hormone and the skin.

Authors:  Andrzej Slominski; Blazej Zbytek; Michal Zmijewski; Radomir M Slominski; Sobia Kauser; Jacobo Wortsman; Desmond J Tobin
Journal:  Front Biosci       Date:  2006-09-01

Review 6.  Stress and disorders of the stress system.

Authors:  George P Chrousos
Journal:  Nat Rev Endocrinol       Date:  2009-06-02       Impact factor: 43.330

7.  Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1.

Authors:  Augen A Pioszak; Naomi R Parker; Kelly Suino-Powell; H Eric Xu
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 8.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

9.  Sex differences in corticotropin releasing factor-evoked behavior and activated networks.

Authors:  Kimberly R Wiersielis; Brittany Wicks; Hannah Simko; Sarah R Cohen; Sabina Khantsis; Nausheen Baksh; David E Waxler; Debra A Bangasser
Journal:  Psychoneuroendocrinology       Date:  2016-07-28       Impact factor: 4.905

Review 10.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.